Review
Open access
Aug 2026
A Review on Pharmacology and Resistance Mechanisms for Sunvozertinib in EGFR Exon 20 Insertion–Mutant Non-Small Cell Lung Cancer
Sunvozertinib provides a compelling pharmacological option that bridges long-standing unmet needs in precision thoracic oncology and explores frontline positioning against systemic chemo-immunotherapy combinations, while companion biomarker discovery aims to define individualized treatment sequencing.
I. Kumar, N. Sharma, Sonia Sharma et al.
· Journal of Pharma Insights a... · 0 citations